Experimental blood test detects early breast cancer and predicts recurrence

Now researchers from the laboratories of Guy Ron at the Hebrew University of Jerusalem and Efrat Shema at the Weizmann Institute of Science have developed a blood test that distinguishes with high accuracy between women with early-stage breast cancer and healthy women.

The findings, published in Nature, grew out of a collaboration with physicians at Kaplan Medical Center in Rehovot. Together, the researchers decoded the distinctive epigenetic signatures of breast tumors and identified a particularly aggressive population of cells lurking within them.

If DNA is the cookbook that every cell in the body keeps on its shelf, epigenetic tags are the sticky notes and bookmarks telling the cell which recipes to follow and how often to use them. In cancer cells, things can go wrong both with the recipes themselves, through genetic mutations, and with the instructions for using them.

Sign up for Blog Updates